Wealth Alliance’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
Wealth Alliance's GMAB Position: Q3 2026 in Review
Wealth Alliance reduced its Genmab (GMAB) stake by 1.4% in Q3 2026, selling an estimated $5.95K and leaving 13,026 shares worth $465K. The position accounts for 0.04% of the portfolio, ranked #330.
Wealth Alliance first reported a position in GMAB in Q2 2020 and has held it in 23 quarters since. 258 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Wealth Alliance held 13,026 shares of Genmab worth $465K as of Q3 2026.
- Wealth Alliance sold 188 Genmab shares in Q3 2026, an estimated $5.95K.
- Genmab made up 0.04% of Wealth Alliance's portfolio in Q3 2026, its #330 holding.
- Wealth Alliance first reported a position in Genmab in Q2 2020 and has held it in 23 quarters since.
- 258 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Wealth Alliance's 13F filing for Q3 2026, filed 13 Nov 2026.